# Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

> **NCT00664417** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 375 (actual)

## Conditions studied

- Influenza
- Orthomyxoviridae Infections

## Interventions

- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Monovalent subvirion H5N1 influenza vaccine
- **BIOLOGICAL:** Physiological saline

## Key facts

- **NCT ID:** NCT00664417
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-09
- **Final completion:** 2010-08
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2012-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664417, "Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00664417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*